South Korea · Delayed Price · Currency is KRW Myung In Pharmaceutical LTD. Company Description
Myung In Pharmaceutical LTD., a pharmaceutical company, manufactures ETC and OTC drugs.
It offers products in the areas of thrombosis and anti-platelet, anti-hypertensive, anti-angina, anti-parkinson, anti-dementia, anti-epileptics, anti-schizophrenia, anti-depressants, adhd, anti-insomnia, gum disease treatment, gastrointestinal, cold-cough medicine, anti-fever, anti-pain, anti-inflammation agent, nutrition supplements and other pharmaceuticals.
The company also provides APIs, such as benztropine mesylate, benidipine hcl, clopidogrel bisulfate, haloperidol, paroxetine hcl, pimozide, quetiapine fumarate, rasagiline mesylate, risperidone, sumatriptan succinate, trazodone hci, triazolam, levetiracetam, carbamazepine, benserazide hydrochloride, escitalopram oxalate, vortioxetine hbr, brivaracetam, edoxban tosylate, opicapone, brexpiprazole, guanfacine hydrochloride, lacosamide, lurasidone hydrochloride.
Myung In Pharmaceutical LTD. was founded in 1985 and is based in Hwaseong-si, South Korea.
| Country | South Korea |
| Founded | 1985 |
| Industry | Pharmaceutical Preparations |
| Employees | 335 |
| CEO | Hang-Myung Lee |
Contact Details
Address: 361-12, Noha-gil Hwaseong-si South Korea | |
| Phone | 82 2 587 9060 |
| Website | myunginph.co.kr |
Stock Details
| Ticker Symbol | 317450 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hang-Myung Lee | Chief Executive Officer |